Wellington Management Group’s Atea Pharmaceuticals AVIR Stock Holding History
Bought
Maintained
Sold
Other funds holding AVIR
BCM
Wellington Management Group's AVIR Position: Q3 2026 in Review
Wellington Management Group increased its Atea Pharmaceuticals (AVIR) stake by 19% in Q3 2026, buying an estimated $204K and bringing the position to 246,582 shares worth $1.28M. The position accounts for ﹤0.01% of the portfolio, ranked #1677.
Wellington Management Group first reported a position in AVIR in Q4 2020 and has held it in 21 quarters since. The position peaked at $10.5M in Q2 2021. 126 funds tracked by Wall St. Rank hold AVIR as of Q3 2026.
- Wellington Management Group held 246,582 shares of Atea Pharmaceuticals worth $1.28M as of Q3 2026.
- Wellington Management Group bought 39,797 Atea Pharmaceuticals shares in Q3 2026, an estimated $204K.
- Atea Pharmaceuticals made up ﹤0.01% of Wellington Management Group's portfolio in Q3 2026, its #1677 holding.
- Wellington Management Group first reported a position in Atea Pharmaceuticals in Q4 2020 and has held it in 21 quarters since.
- Wellington Management Group's Atea Pharmaceuticals position peaked at $10.5M in Q2 2021.
- 126 funds tracked by Wall St. Rank held Atea Pharmaceuticals as of Q3 2026.
Based on Wellington Management Group's 13F filing for Q3 2026, filed 16 Nov 2026.